Enthera Pharmaceuticals
Italy - Milan
Pharmaceutical1 H-1B visas (FY2023)Focus: IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins
Enthera Pharmaceuticals is a life sciences company focused on IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Products & Portfolio (1)
1 discontinued product not shown
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2016
Portfolio: 2 approved products
H-1B (2023): 1 approval
Portfolio Health
Peak1 (50%)
LOE Approaching1 (50%)
2 total products
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub